Simi M. Odeneye, Mph
About Simi M. Odeneye, Mph
Simi M. Odeneye, MPH, is the Associate Director and Senior Clinical Scientist in Oncology Clinical Sciences at Bristol Myers Squibb, with extensive experience in clinical trial management and development.
Company
Simi M. Odeneye currently works at Bristol Myers Squibb as an Associate Director, Senior Clinical Scientist in Oncology Clinical Sciences. Bristol Myers Squibb is known for its innovation in cancer treatment, and Simi plays a key role in advancing the company’s oncology clinical trials.
Title
Simi M. Odeneye holds the title of Associate Director, Senior Clinical Scientist at Bristol Myers Squibb. In this role, she co-leads study team meetings, collaborates with cross-functional teams, and manages all phases of clinical trial activities.
Education and Expertise
Simi M. Odeneye obtained a Master’s Degree in Epidemiology and Biostatistics from the State University of New York Downstate Health Sciences University (2014-2016). Additionally, she completed a Clinical and Translational Science Program - Career Enhancement Track at Weill Cornell Graduate School of Medical Sciences in 2014. She earned her Bachelor's Degree in Biology/Biological Sciences from City University of New York-College of Staten Island (2007-2011).
Background
Simi M. Odeneye has a diverse background in clinical science and oncology. Before her current role, she worked as a Clinical Scientist in Early Stage Clinical Development at Merck (2016-2020), and at Memorial Sloan Kettering Cancer Center as a Research Study Specialist (2012-2016). She also has experience as a Laboratory and Research Technician at City University of New York-College of Staten Island in 2011.
Achievements
Simi M. Odeneye has extensive experience with multiple oncology clinical trials, supporting clinical development planning, and leading study startup, conduct, and close-out activities. She has been involved in protocol and ICF development, data generation, and validation. Furthermore, she has taken part in drafting, reviewing, and validating clinical study reports and regulatory documents.